Human LRH-1/NR5A2 Antibody
R&D Systems, part of Bio-Techne | Catalog # PP-H2325-00
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human, Mouse
Applications
Validated:
Direct ELISA, Immunoprecipitation, Western Blot
Cited:
Chromatin Immunoprecipitation (ChIP), Immunocytochemistry, Immunohistochemistry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG3 Clone # H2325
Product Specifications
Immunogen
Recombinant human LRH-1/NR5A2
aa 161-280
aa 161-280
Specificity
This antibody specifically recognizes human LRH-1 alpha and LRH-1 beta and
cross-reacts with mouse and rat LRH-1. Not yet tested in other species.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG3
Applications for Human LRH-1/NR5A2 Antibody
Application
Recommended Usage
Direct ELISA
This antibody can be used at 2 ng/mL with the appropriate
secondary reagents to detect human LRH-1.
Immunoprecipitation
Optimal dilutions should be determined by each
laboratory.
Western Blot
This antibody can be used at 1 μg/mL with the appropriate
secondary reagents to detect human LRH-1.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
A liquid formulation in physiologic saline with 0.1% NaN3.
Shipping
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
This antibody is stable for greater than six months when held at -20 °C in a
manual defrost freezer or at -70 °C. Upon thawing, the antibody can be
stored at 2-8 °C for at least 1 month without detectable loss of activity. Avoid
repeated freeze-thaw cycles.
Background: LRH-1/NR5A2
Long Name
Liver Receptor Homolog 1/Nuclear Receptor Subfamily 5, Group A, Member 2
Alternate Names
B1F2, FTZ-F1 beta, LRH1, NR5A2
Entrez Gene IDs
2494 (Human)
Gene Symbol
NR5A2
Additional LRH-1/NR5A2 Products
Product Documents for Human LRH-1/NR5A2 Antibody
Product Specific Notices for Human LRH-1/NR5A2 Antibody
For research use only
Loading...
Loading...
Loading...